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The striatum serves as the main input to the basal ganglia, and is key for the regulation
of motor behaviors, compulsion, addiction, and various cognitive and emotional states.
Its deterioration is associated with degenerative disorders such as Huntington’s disease.
Despite its apparent anatomical uniformity, it consists of intermingled cell populations,
which have precluded straightforward anatomical sub-classifications adhering to
functional dissections. Approximately 95% of the striatal neurons are inhibitory projection
neurons termed medium spiny neurons (MSNs). They are commonly classified according
to their expression of either dopamine receptor D1 or D2, which also determines their
axonal projection patterns constituting the direct and indirect pathway in the basal
ganglia. Immunohistochemical patterns have further indicated compartmentalization of
the striatum to the striosomes and the surrounding matrix, which integrate MSNs of
both the D1 and D2 type. Here, we present a transgenic mouse line, Gpr101-Cre, with
Cre recombinase activity localized to matrix D1 and D2 MSNs. Using two Gpr101-Cre
founder lines with different degrees of expression in the striatum, we conditionally
deleted the vesicular inhibitory amino acid transporter (VIAAT), responsible for storage
of GABA and glycine in synaptic vesicles. Partial ablation of VIAAT (in ∼36% of MSNs)
resulted in elevated locomotor activity compared to control mice, when provoked with
the monoamine reuptake inhibitor cocaine. Near complete targeting of matrix MSNs led
to profoundly changed motor behaviors, which increased in severity as the mice aged.
Moreover, these mice had exaggerated muscle rigidity, retarded growth, increased rate of
spontaneous deaths, and defective memory. Therefore, our data provide a link between
dysfunctional GABA signaling of matrix MSNs to specific behavioral alterations, which
are similar to the symptoms of Huntington’s disease.
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Introduction
The striatum constitutes the largest component of the basal ganglia, integrating signals from
the cerebral cortex, and is central for appropriate selection of behavioral action. Its dysfunc-
tion has been associated with classical motor disorders such as Parkinson’s disease, Huntington’s
disease, and dystonia, but also with compulsivity, addiction, hyperactivity disorder, and depression
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(Hyman and Malenka, 2001; Yin and Knowlton, 2006; Critten-
den and Graybiel, 2011; Shepherd, 2013). Yet, surprisingly little
is known about its sub-compartmentalization and the behavioral
correlates. The main barrier for such interrogation has been its
apparent homogeneity, which obscures its inner compartments.
The identification of two intermingled populations of MSNs,
expressing either dopamine receptor D1 or D2 was an impor-
tant step in our understanding of striatal subdivisions (Gerfen
et al., 1990). The efferent projections of these molecularly defined
populations constitute two separate pathways in the basal ganglia
(Albin et al., 1989; Gerfen, 1992); a direct pathway (D1) project-
ing to the substantia nigra pars reticulata (SNr) and the internal
globus pallidus (GPi), and an indirect pathway (D2) projecting
to the external globus pallidus (GPe). Recently, the functional
roles and precise distribution of these MSN sub-populations are
beginning to become characterized in detail by use of the Cre/lox
system (Bateup et al., 2010; Santini et al., 2012; Gangarossa et al.,
2013; Rebholz et al., 2013; Arango-Lievano et al., 2014; Daigle
et al., 2014).
A second level of sub-striatal segregation is that of the stri-
atal patches and the surrounding matrix (Pert et al., 1976; Ger-
fen, 1984, 1992; Herkenham et al., 1984; Gerfen et al., 1985;
Jimenez-Castellanos and Graybiel, 1989), also referred to as the
striosome and the matrisome compartments (Crittenden and
Graybiel, 2011). The first clue to this organization was the patchy
enrichment of opiate receptors (Pert et al., 1976). Later, these
zones were shown to be weak in acetylcholinesterase staining
(Graybiel and Ragsdale, 1978; Herkenham and Pert, 1981). With
the help of these and other molecular markers such as calbindin,
that demarks the matrix (Gerfen et al., 1985), a coherent patch-
matrix distribution in both the dorsal and the ventral striatum
emerged (Gerfen, 1992).
The striatal patches receive most of their input from lim-
bic regions, while the matrix receives input from the associative
forebrain and sensorimotor cortex (Gerfen, 1984; Bolam et al.,
1988; Ragsdale and Graybiel, 1988; McDonald, 1992; Flaherty
and Graybiel, 1994). At the output side, both patch and matrix
compartments participate in the direct and indirect pathways,
but only patches project to the substantia nigra pars compacta
(SNc) (Crittenden and Graybiel, 2011). These input and output
divisions suggest that the activity of neurons located in patches
or matrix promote different behaviors, but the lack of means
to specifically target these compartments make their interro-
gation problematic, often relying on lesion studies. Transgenic
mice are now emerging as useful tools to visualize these struc-
tures (Gerfen et al., 2013), including the Proenkephalin-eGFP
mouse that preferentially label the matrix (Koshimizu et al.,
2008), the Tyrosine Hydroxylase-eGFP (Miura et al., 2007) and
Nr4a1-eGFP (Davis and Puhl, 2011) mice that mark the strio-
somes. Attempts to also investigate functions have used genetic
manipulations, which have demonstrated that a selective change
in the glutamate receptor-anchoring protein Homer in strio-
somes significantly affects motor performance (Tappe and Kuner,
2006).
Inhibitory neurotransmission in the adult nervous system is
mainly mediated by release of γ-aminobutyric acid (GABA) and
glycine from synaptic vesicles. The main vesicular transporter
responsible for the filling of vesicles at GABAergic and glycinergic
synapses is member 1 of the solute carrier family 32 (SLC32A1),
also referred to as vesicular inhibitory amino acid transporter
(VIAAT) or vesicular GABA transporter (VGAT). Whereas,
GABAergic inhibition plays an essential role in the brain, both
GABA and glycine act as the primary inhibitory neurotransmit-
ters in the brainstem and spinal cord. Loss of GABA/glycine-
mediated neurotransmission through deletion of VIAAT causes
a drastic reduction of neurotransmitter release in both GABAer-
gic and glycinergic neurons (Wojcik et al., 2006), which leads
to embryonic lethality in null-mutants, presumably caused by
omphalocele. Since constitutive Viaat knock-out (KO) mice die
between E18.5 and birth, a conditional approach is required for
analyzing the full spectrum of effects controlled by vesicular
GABA and glycine release in the adult nervous system. Our group
has previously addressed neuronal circuit functions in the mouse
hippocampus using such an approach, where VIAAT mediated
transmission was specifically removed from oriens lacunosum-
moleculare cells through conditional deletion of VIAAT (Leao
et al., 2012).
Here, we present the generation of a transgenic mouse line,
Gpr101-Cre, which expresses Cre recombinase predominantly in
matrix MSNs. Furthermore, by Gpr101-Cre mediated deletion
of VIAAT we have identified behavioral changes that emerge
from disruption of GABA signaling in neurons of the striatal
matrix.
Results
Generation and Characterization of Gpr101-Cre
Mice
We generated mice carrying Cre recombinase under the reg-
ulatory sequence of mouse Gpr101, an orphan receptor of the
seven transmembrane domain type that is encoded in the X-
chromosome, as described in detail in the Methods Section. In
brief, we produced a linearized bacterial artificial chromosome
(BAC) containing Cre in frame at the ATG site ofGpr101, flanked
by 150 kbp of upstream and 30 kbp of downstream sequence (Fig-
ure S1). This BAC transgene was introduced into the genome
of C57BL/6 by pronuclear injection, and resulted in the gener-
ation of two Gpr101-Cre positive founder individuals. We bred
these founders on a C57BL/6 background, giving rise to two
independently maintained Grp101-Cre lines, which we termed
“Grp101-Cre-A” and “Grp101-Cre-B.” To investigate the activity
of Cre in the mouse brain, we crossed the two Gpr101-Cre lines
to the reporter Gt(ROSA)26Sortm14(CAG−tdTomato)Hze (dtTomato,
Ai14) (Madisen et al., 2010). In the progeny of these mice, red
fluorescent protein (RFP) is expressed in cells in which Cre has
been active at any time during development or postnatal life.
Most markedly, we observed RFP throughout the striatum of
both Gpr101-Cre lines (Figure 1). Thus, an element within the
Gpr101-Cre gene sequence drives striatal expression. Gpr101-
Cre-A activated RFP was dense throughout the striatum, but
also showed wider distribution of activity in other brain regions,
such as the amygdala, hippocampus, hypothalamus, and in cor-
tical layers (Figure 1A). While expression in the amygdala was
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FIGURE 1 | Gpr101-Cre expression in the brain. Fluorescence microscopy images showing coronal brain sections of (A) Gpr101-Cre-Atg/wt:dtTomatotg/wt and
(B) Gpr101-Cre-Btg/wt:dtTomatotg/wt reporter mice. Numbers denote approximate bregma coordinates.
found in a limited number of cells, the neuropil was giving a
moderate red fluorescent signal. In the hippocampus, a frac-
tion of pyramidal cells were labeled. Gpr101-Cre-B, on the other
hand, showed fewer affected neurons within the striatum com-
pared to Gpr101-Cre-A, but instead provided remarkable stri-
atal specificity (Figure 1B). Intrigued by the restricted expression
pattern, we characterized this founder line in more detail. The
Gpr101-Cre-B activity was foremost concentrated to the caudate
putamen (CP), nucleus accumbens (ACB), and olfactory tuber-
cle (OT) (Figure 2A). We also observed limited expression in
other brain regions including scattered hippocampal pyramidal
neurons, neurons in the ventral retrosplenial area, scattered cor-
tical neurons, and few cerebral neurons (Figure 2A, Figure S2).
Additionally, we noticed red fluorescence in sporadic cells of
arborescent appearance throughout the brain (Figure 2A, Fig-
ure S2). Some of these bush-like cells co-stained with antibodies
for the glial fibrillary acidic protein (GFAP) whereas none co-
stained with the neuronal marker NeuN (Figure S3), suggesting
that these cells were astrocytes rather than neurons. In spinal cord
sections, we found RFP labeling of sparse neurons in the dor-
sal horn and cells of astrocytic appearance throughout the gray
commissure (Figure S4). Since the vast majority of all Gpr101-
Cre-B labeled neurons were located in the striatum, we further
investigated this population.
Medium Spiny Neurons of Both D1 and D2 Type
Medium spiny neurons (MSNs) are characterized by their expres-
sion of the dopamine- and cAMP-regulated phosphoprotein
Mr∼32,000 (DARPP32) (Ouimet and Greengard, 1990; Sven-
ningsson et al., 2004; Matamales et al., 2009). Cell counting
revealed that essentially all (∼98%) of the Gpr101-Cre-B positive
cells in the striatum co-stained with an antibody for DARPP32,
and that around a third (∼36%) of the DARPP32 stained cells
were also Gpr101-Cre-B positive (Figure 3A). We found no
Gpr101-Cre-B positive cell that co-labeled with choline acetyl-
transferase (ChAT). Moreover, Gpr101-Cre-B positive cells had
dendrite formations and small soma diameters characteristic of
MSNs (Figure S5) and distinct from striatal cholinergic interneu-
rons (Figure S6). Therefore, we concluded that Gpr101-Cre-B
delineates a population of MSNs in the striatum.
We next wanted to know whether Gpr101-Cre-B labeled
MSNs of the direct pathway or the indirect pathway of the
basal ganglia. Therefore, we performed staining experiments for
dopamine D1 and D2 receptors, respectively. To label clearly dis-
tinguishable soma of dopamine receptor positive cells for count-
ing, we performed fluorescent in situ hybridization of receptor
D1 or D2 mRNA combined with immuno-labeling of Gpr101-
Cre-B positive cells (we applied immuno-labeling of RFP, since
the original reporter fluorescence was bleached by the in situ
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FIGURE 2 | Gpr101-Cre-B expression and projections. Fluorescence
microscopy images showing (A) a sagital brain section of Gpr101-Cre-Btg/wt:
dtTomatotg/wt (RFP) combined with immunohistochemistry for Tyrosine
hydroxylase (TH). (B) Coronal section at the vertical mark intersecting SN in
(A) of Gpr101-Cre-Btg/wt:dtTomatotg/wt combined with
immunohistochemistry for TH. (C) High resolution confocal microscopy image
of Gpr101-Cre-Btg/wt:dtTomatotg/wt combined with immunohistochemistry
for VIAAT, showing RFP/VIAAT positive terminals in the SNr.
procedure). We found that ∼41 and 53% of the Gpr101-Cre-B
positive cells co-stained with D1 and D2 positive cells, respec-
tively (Figures 3B,C). In further agreement with the conclusion
that Gpr101-Cre-B marked MSNs of both the direct and the
indirect pathway, we observed that Gpr101-Cre-B positive cells
formed dense projections that terminated in both the GPi and
GPe as well as in the SNr (Figure 2, Figure S2). GP and SNr
were simultaneously deficient of RFP labeled soma (Figure S7),
indicating that Gpr101-Cre-B cells project to, but not from, these
nuclei.We therefore concluded thatGpr101-Cre-Bmarked a pop-
ulation of MSNs that include parts of both the direct and the
indirect pathway of the basal ganglia.
A Marker for the Striatal Matrix
We observed distinct unlabeled patches of tissue in the stria-
tum of Gpr101-Cre-B:dtTomato mice (Figure 4A), reminiscent
of the concept of a striatal mosaic (Gerfen, 1992). To investi-
gate whether the lack of Cre activity in these regions correlated
with the shape of striosomes, we performed calbindin immuno-
histochemistry. Calbindin 28K (CALB) is known to label the
matrix, but show a diffuse decrease of labeling in striosomes
(Gerfen et al., 1985; Difiglia et al., 1989; Jones, 1998; Matamales
et al., 2009). Indeed, we found a decreased CALB immuno-stain
in Gpr101-Cre-B deficient patches (Figure 4B). Previous studies
have shown that matrix MSNs project to the SNr, whereas strio-
some MSNs project directly to the SNc (Gerfen, 1984; Fujiyama
et al., 2011;Watabe-Uchida et al., 2012). In line with this,Gpr101-
Cre-B terminals were enriched in the SNr but were not found
in the SNc (Figures 2A,B, Figures S2, S7). Thus, the Gpr101-
Cre-B mouse line provides a strategy to target and function-
ally interrogate MSNs of the striatal matrix, while avoiding
striosomes.
Phenotypic Consequences upon Deletion of
VIAAT in the Striatal Matrix
Wewanted to identify behaviors that depend on correct signaling
through the Gpr101-Cre-B positive population of MSNs. VIAAT,
responsible for the loading of GABA and glycine into synaptic
vesicles (McIntire et al., 1997; Sagne et al., 1997; Chaudhry et al.,
1998), is the single member of its family and key for GABAergic
transmission in the brain (Gasnier, 2004). As expected, Gpr101-
Cre-B positive MSNs expressed Viaat mRNA (Figure S8), and
VIAAT protein was found in Gpr101-Cre-B positive terminals
(Figure 2C). We conditionally deleted VIAAT using our novel
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FIGURE 3 | Gpr101-Cre demarks medium spiny neurons of both D1
and D2 type. Confocal microscopy images, showing brain sections of
Gpr101-Cre-Btg/wt:dtTomatotg/wt combined with staining for either
DARPP32 protein, D1 mRNA, or D2 mRNA. The leftmost panels show
high resolution images in the striatum. The middle panels show wide-field
images, CP: caudate putamen, Ctx: cortex. The rightmost panels show
the percentage of cells with dual labeling (yellow) and single labeling
(green or red) in cell counting experiments. #individuals = 2 and
#sections = 10 per staining. (A) Immunohistchemical staining of the
medium spiny neuron marker DARPP32 in
Gpr101-Cre-Btg/wt:dtTomatotg/wt. (1) DARPP32pos:RFPneg cell, (2)
DARPP32pos:RFPpos cell. (B) In situ hybridization of dopamine receptor 1
in Gpr101-Cre-Btg/wt:dtTomatotg/wt. (1) RFPpos:D1neg cell, (2)
RFPneg:D1pos cell, (3) RFPpos:D1pos cell. (C) In situ hybridization of
dopamine receptor 2 in Gpr101-Cre-Btg/wt:dtTomatotg/wt. (1)
RFPpos:D2neg cell, (2) RFPneg:D2pos cell, (3) RFPpos:D2pos cell.
Gpr101-Cre-B Cre line and cross-bred these mice with mice car-
rying a conditional (floxed) Viaat allele (Tong et al., 2008). This
produced Gpr101-Cre-Btg/wt :Viaatlx/lx knock-out (KOB) mice,
in which Viaat was conditionally deleted (Figure S9), as well
as Gpr101-Cre-Bwt/wt :Viaatlx/lx littermate controls (Ctrls). We
investigated these mice in a range of behavioral tests associated
with diverse brain functions. Starting with the gross physiological
parameters, KOB mice did not differ from Ctrls in weight neither
at the start of the trial (6 wks) nor at 26 wks (P > 0.05, t-test,
Figure 5A). Also, they did not differ in their grip strength (P >
0.05, t-test, Figure 5B) or in the frequency of spontaneous deaths
(zero spontaneous deaths at postnatal day 200 in both groups;
n = 13 in each group). To test whether KOB mice displayed
changes that were reflected in their social status in the housing
cages, we subjected weight-matched littermates to a dominance
tube test. In this test, two mice were introduced in each end of a
transparent tube with the approximate diameter of a mouse, so
that when the mice met inside the tube one of them had to retreat
by backing while the other one pushed forward (winner). Each
KOB:Ctrl pair underwent four tube test trials, and mice with at
least 3/4 wins were classified winners. There was no significant
difference in the number of wins by KOB and Ctrl (P > 0.05,
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FIGURE 4 | Gpr101-Cre delineates the striatal matrix. Confocal
microscopy images showing (A) Gpr101-Cre-Btg/wt:dtTomatotg/wt
combined with immunohistochemistry for DARPP32. The arrows point to
patches in CP lacking RFP staining. Red: RFP, green: DARPP32, blue: DAPI.
(B) Gpr101-Cre-Btg/wt:dtTomatotg/wt combined with immunohistochemistry
for the matrix marker calbindin (CALB). Red: RFP, green: CALB, blue: DAPI.
binomial test, Figure 5C). We next applied the marble burying
test to probe obsessive and repetitive perseverative behaviors.
Each mouse was placed in a clean housing cage with 18 black
glassmarbles placed over a flat layer of sawdust bedding, and after
30min in the arena the number of buried marbles was counted.
This did not reveal any differences between the two groups (P >
0.05,Wilcoxon signed-rank test, Figure 5D). To test anxiety, fear,
and exploratory behavior, we used an elevated plus maze. In both
the KOB and Ctrl group, we found that the mice avoided the open
arm (P < 10−3 open vs. center, P < 10−18 open vs. closed, t-
test), assuring that the open arm represented an adverse stimuli
in our set-up. More interestingly, the KOB mice spent more time
in the open arm (P < 0.05, t-test), and re-entered the open arm
more frequently (P < 0.05, Wilcoxon signed-rank test) than Ctrl
mice (Figure 5E). To probe escape behavior and despair under
an acutely stressful scenario, we performed a forced swim test.
Each mouse was placed for 5min in a transparent, water-filled,
cylindrical container, fromwhich they could not escape. The head
of the mouse was tracked by computer software to follow their
swim speed during the course of the experiment. This showed
that KOB mice produced significantly less movement than the
Ctrls during the initial 90 seconds into the trial (P < 0.01,
t-test, Figure 5F), while after around 3min, both groups con-
verged at the same constant speed. We measured the time that
the mice spent swimming, floating, or escaping/climbing against
the cylinder wall, during the initial 90 s of the forced swim test
and found that KOB and Ctrl spent similar amount of time try-
ing to escape, but KOB mice spent significantly less time swim-
ming and more time floating (P < 0.01, t-test, Figure 5F). To
test whether KOB mice had altered sensorimotor coordination or
balance ability, we subjected each mouse to three consecutive tri-
als in the rotarod test, but found no difference in any of the three
trials (P > 0.05, t-test, Figure 5G). The striatum is crucial for the
regulating voluntary movement, and ablation of the central sig-
naling protein DARPP32 in D1 and D2 MSNs have been demon-
strated to have opposite effects on locomotor behavior (Bateup
et al., 2010), decreasing or increasing basal locomotion, respec-
tively. Hence, we tracked spontaneousmovement in an open field
chamber. In this test, KOB and Ctrl mice presented equal basal
locomotor activity (P > 0.05, t-test, Figure 5H). However, when
the mice were provoked with the monoamine reuptake inhibitor
cocaine, which induces locomotion, we found a larger cocaine-
induced locomotion increase in KOB mice compared to Ctrls
(P < 0.01, t-test, Figures 5I,J). This showed that the consecutive
loss of VIAAT in the Gpr101-Cre-B activated cells has conse-
quences for signaling and functions associated with the dopamine
system.
Consequently, we concluded that GABA signaling of matrix
MSNs has a role in the regulation of locomotion. We reasoned
that since Gpr101-Cre-B did not target all matrix MSNs, but
only ∼36% (Figure 3A), adaptive compensation of the remain-
ing untargeted MSNs might have prevented the manifestation of
more severe locomotion phenotypes. To evaluate this possibil-
ity, we turned to the Gpr101-Cre-A line with its broader expres-
sion. CALB staining on Gpr101-Cre-A:dtTomato mice showed
that also this line expressed Cre in the striatal matrix (Figure 6A),
but incorporated virtually all matrix MSNs in contrast to the
more limited targeting in Gpr101-Cre-B. Occasionally, some few
cells were found in the border zone between the matrix and strio-
some in the Gpr101-Cre-A, something we did not observe in
the Gpr101-Cre-B. When handling Gpr101-Cre-Atg/wt :Viaatlx/lx
(KOA) mice, we soon noticed that these mice were slightly
smaller compared to their littermate controls, and we there-
fore monitored their weights through postnatal development.
This showed that KOA and controls gained weight at a simi-
lar rate during the two first weeks of life, but after this point
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FIGURE 5 | Behavioral phenotypes upon partial matrix MSN VIAAT
deletion. Results from behavioral tests using Gpr101-Cre-Btg/wt:Viaatlx/lx
(KOB, black) and Gpr101-Cre-Bwt/wt:Viaatlx/lx (Ctrl, white). (A) Body weight
at 6 and 26 wks. (B) Forelimb grip strength in three consecutive trials. (C)
Dominance tube test. Proportion of wins. (D) Marble burying test. Number of
marbles buried out of 18, shown as violin plots with the medians marked by
circles. (E) Elevated plus maze. Proportion of time spent in areas during a
10min trial, and number of open arm entries, shown as violin plots with the
medians marked by circles. (F) Forced swim test. Average swim speed
during 30 s segments of time over a 5min trial. Barplots showing the percent
time spent floating, swimming, and escaping (climbing against the cylinder
wall), during the three first 30 s segments of time in the trial. (G) Rotarod test.
Rotations per minute (rpm) at which the mice fell off the rotor as measured in
three consecutive trials. (H) Basal locomotion. Number of dual beam breaks
during 5min segments of time over a 50min trial. (I) Cocaine-induced
locomotion. The basal locomotion was first monitored during 25min, and at
the time-point marked by the arrow 15µg/g body weight of cocaine
hydrochloride was injected. (J) Injection control. The mice were monitored
during 25min and injected with physiological saline solution at the time-point
marked by the arrow (#KOBinj−ctrl = 6, #Ctrlinj−ctrl = 6). Bars and boxes
show the group averages ±SEM. #KOB = 11, #Ctrl = 11 if not stated
otherwise. P-values: *P < 0.05 and **P < 0.01, according to two-sided
t-tests [A, B, E(time), F–J]; two-sided binomial test (C); or two-sided
Wilcoxon signed-rank test [D, E(entries)].
KOA mice showed arrested growth that persisted into adult-
hood (P < 0.05, t-test, Figure 6B). Moreover, KOA mice had
severely decreased survivability (P < 10−9, Fischer’s exact test,
Figure 6C).
We also noticed that KOA mice walked with jerky or some-
what stiff limb movements. Grip strength tests indicated that
KOA mice had exaggerated muscle rigidity (P < 0.01, t-test,
Figure 6D). We monitored basal locomotion in KOA and Ctrls
from age P28 and 5 weeks onwards, and found that as the KOA
mice aged they developed increasingly exaggerated locomotor
behaviors (P < 0.001, t-test, Figure 6E), and presented rearing
behaviors not seen in control mice (P < 0.001, t-test, Figure 6F).
To further investigate the KOA locomotor phenotype, we ana-
lyzed their gait letting the mice traverse a 1m× 50mm track and
recording their footfall patterns on absorbent paper (Figure 6G).
This test demonstrated that KOA mice walked with significantly
shorter strides (P < 0.01, t-test) and had slightly wider spacing
between the forelimbs (P < 0.05, t-test).
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FIGURE 6 | Behavioral phenotypes upon broad matrix MSN VIAAT
deletion. Results from CALB staining and behavioral tests using
Gpr101-Cre-Atg/wt:Viaatlx/lx (KOA, black) and Gpr101-Cre-Awt/wt:
Viaatlx/lx (Ctrl, white). (A) Confocal microscopy images showing Gpr101-
Cre-Atg/wt:dtTomatotg/wt combined with immunohistochemistry for
CALB. (B) Body weights up to adult age. (C) Survivability during 200
days (#KOA = 22, #Ctrl = 24), P-value according to Fischer’s exact
test at day 200. (D) Forelimb grip strength in 10 consecutive trials. (E)
Basal locomotion. Number of dual beam breaks during 10min segments
of time over a 60min trial. (F) Rearing activity. Number of beam breaks
during 10min segments of time over a 60min trial. (G) Gait analysis.
Footprints recorded from KOA and Ctrl mice during locomotion (hind
paws: green, fore paws: red) and summary statistics. (H) Object
recognition test. A schematic illustration of the paradigm, and the
proportion of time spent interacting with objects. Bars and boxes show
the group averages ±SEM. #KOA = 5, #Ctrl = 6. P-values: *P < 0.05,
**P < 0.01, ***P < 0.001, according to two-sided t-tests if not stated
otherwise.
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In addition to its role in regulating locomotor functions,
the striatum is known to participate in a variety of cognitive
functions, including working memory (Lovinger, 2010; Palmiter,
2011). Notably, we also found some Gpr101-Cre-A activity in the
hippocampus, which is well-known to control memory function.
However, this Cre expression was limited to excitatory pyrami-
dal neurons that are unlikely to be affected by the deletion of
VIAAT. We tested memory in KOA mice in a novel object recog-
nition paradigm using an E-maze setup (Figure 6H). Whereas
control mice showed strong preference for interacting with novel
objects, KOA mice did not discriminate between the familiar
and the novel object (P < 0.001, t-test, on the difference in
preference).
Discussion
Here we present the effects of conditionally deleting the GABA
presynaptic vesicular transporter VIAAT in MSNs of the stri-
atal matrix. We characterized the novel Cre line Gpr101-Cre-
B and found that it predominantly expressed active Cre pro-
tein in MSNs of both the D1 and D2 type in the striatal
matrix, and had projections to the GPe, GPi, and SNr. Dele-
tion of VIAAT in limited parts of the matrix (∼36% of MSNs),
driven by the Gpr101-Cre-B mouse line, had mild effects with
no major changes in weight, motor abilities, spontaneous loco-
motion, defensive or social behaviors. In contrast, we observed a
reduced level of anxiety, as measured by the increased number
of both entries and time spent in the open arm of the elevated
plus maze. Moreover, and perhaps most striking, Gpr101-Cre-
Btg/wt :Viaatlx/lx mice were hyper-responsive to cocaine-induced
locomotion (Figure 5I). The VIAAT lox allele has been success-
fully used in several previous studies (e.g., Leao et al., 2012;
Rahman et al., 2014), hence, phenotypic effects in Gpr101-Cre-
Btg/wt :Viaatlx/lx mice were expected. Consequently, we found
that loss of VIAAT in the Gpr101-Cre-A line, with its broader
expression incorporating virtually all matrix MSNs, resulted in
more severe phenotypes, including shorter life span, locomo-
tor, and cognitive defects (Figure 6). Clearly, the more limited
deletion was not sufficient to reveal these stronger defects and
could be compensated for, likely by the remaining MSNs in the
Gpr101-Cre-Bmouse line.
However, we also find it plausible that other factors may
have influenced the results, such as other neurotransmitters com-
pensating for the loss of VIAAT or rearrangement of alterna-
tive neuronal circuits regulating the observed behaviors in the
Gpr101-Cre-A- as well as the B-line. Currently, we have not quan-
tified the reduction of GABA release; such analyses will aid in the
interpretation of the consequences of VIAAT deletion. Circuit
rearrangements are certainly possible in light of data suggest-
ing the presence of subspecific afferent and efferent connections
to the matrix and the striosomes. MSNs in the matrix, but not in
the striosomes, receive input from ontogenetically younger corti-
cal layers, such as the upper layer V in the somatosensory cortex
(Wilson, 1987; Gerfen, 1989; Saka and Graybiel, 2003; Critten-
den and Graybiel, 2011). Moreover, there is also evidence of a
striosome specific pathway to the substantia nigra pars compacta
(Gerfen, 1984; Jimenez-Castellanos and Graybiel, 1989; Tokuno
et al., 2002; Fujiyama et al., 2011), suggesting that striosomal
MSNs are in a position to control the flow of dopamine to the
striatum coming from neurons of the SNc (Crittenden and Gray-
biel, 2011). In support of this, we found that the projections from
Gpr101-Cre-B labeled MSNs were absent in the substantia nigra
pars compacta (Figure 2, Figure S2). Thus, loss of a major trans-
mitter in the matrix neurons would not affect the direct feedback
of dopamine from the pars compacta.More likely, this would lead
to consequences associated with matrix function, influenced by
afferent projections from the somatosensory, motor, and associa-
tion cortices and less influence of the limbic system influenced by
afferents innervating striosomes from the orbitofrontal, anterior
cingulate, and insular cortices (Ragsdale and Graybiel, 1990; Fla-
herty and Graybiel, 1994; Eblen and Graybiel, 1995; Kincaid and
Wilson, 1996; Levesque and Parent, 1998). Hence, to more fully
understand the participation of the MSNs in striatal related func-
tions, the Gpr101-Cre-A- and B-line should be used in tempo-
rally controlled experiments i.e., using a conditionally activated
diphtheria toxin receptor.
Despite possible compensatory mechanisms, the severe phe-
notypes in the Gpr101-Cre-A line makes it worthwhile to com-
pare the observed symptoms with those found in basal ganglia
disorders such as Huntington’s disease. Typically, such patients
loose their ability to control their movements and display jerky,
random, and uncontrollable movements called chorea (Walker,
2007). Patients have a shorter life expectancy at least in part
resulting from poor muscle coordination, difficulty clearing the
lungs and an increased risk of aspirating food or drink result-
ing in eating difficulties and malnutrition (Aziz et al., 2008).
Moreover, cognitive disabilities are common and as the dis-
ease progresses, deficits in short- and long-term memory appear
(Montoya et al., 2006). Interestingly, the phenotypes of the
Gpr101-Cre-A:Viaat KO mice recapitulate some of these symp-
toms, having a shorter life span, locomotor deficits and impaired
memory function (Figure 6). We speculate that the disease pro-
gression in humans and the compensatory mechanisms uphold-
ing normal function to a certain extent in the mouse model,
tentatively explains the similar phenotypes. Although the exact
molecular mechanism has to be worked out, we find the appar-
ent similarities as a reasonable starting point for the further
investigation of matrix MSNs.
The deletion of VIAAT does not include all matrix MSNs in
the Gpr101-Cre-B mice, about 36% of them are affected as esti-
mated by recombination of the tdTomato allele (Figure 3A). Nev-
ertheless, we could observe alterations on locomotor response
induced by cocaine, which would be in line with the expected
role of matrix MSNs based on the inputs from the motor cortex
to the matrix. However, we also observed small but significant
effects on behaviors associated to the limbic system, since the
elevated plus maze and the porsolt forced swim test are primar-
ily designed to measure anxiety and depression-like states. This
questions whether there exists a functional selectivity for patch
and matrix compartments for regulation of particular behaviors.
A caveat to this reasoning is the inherent problem with analysis
of anxiety-like behavior based on observation of motor activity.
Thus, the observed differences in behaviors in the elevated plus
maze or the porsolt swim test might also be due to alterations
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in motor circuits. Moreover, it should be noted that differences
in the novel object recognition test using the Gpr101-Cre-A line
might have been influenced by possible deletion of VIAAT in a
limited number of cells in the amygdala, or in the border zone
between the striosome and matrix compartments (Figure 1A).
Although no previous studies have investigated a matrix-
specific loss of neurotransmitter signaling, comparisons can be
made with mice that have lost MSN functionality. DARPP32, a
crucial component of protein kinase and phosphatase signaling
in MSNs, is essential for biochemical and behavioral responses
in the striatum (Svenningsson et al., 2004). Thus, deletion of
DARPP32 will hamper the functionality of the targeted pathway,
and since DARPP32 is expressed in virtually all MSNs, a dys-
functional protein will affect both the striatonigral and striatopal-
lidal projection pathways. Mice that lack DARPP32 show an
attenuated locomotor responsiveness to a single dose of injected
cocaine (Fienberg et al., 1998), suggesting that the MSN popula-
tion as a whole become less sensitive to dopamine, and as a result
the mice become hypo-locomotive. In contrast, the increased
locomotor response to cocaine in Gpr101-Cre-Btg/wt :Viaatlx/lx
mice suggests that the targeted MSNs are distorting the bal-
ance of inhibitory actions betweenMSN subpopulations.We thus
speculate that under normal conditions, matrix MSNs, or a sub-
population thereof, are involved in reducing locomotor activity.
It has previously been suggested that increased striosome activity
promotes stereotypies whereas matrix activity permits flexibility
inmotor behaviors (Crittenden andGraybiel, 2011). Our findings
here are just beginning to shed some light on matrix MSN func-
tionalities, and clearly, more detailed experiments are required
to corroborate their functional role, for example by investigat-
ing the responses of Gpr101-Cre-Btg/wt :Viaatlx/lx mice to other
psychostimulant drugs.
Nevertheless, this is the first example of a study that specif-
ically targets the signaling of matrix MSNs. As such, it repre-
sents a significant advance in the understanding of how the neu-
rocircuitry of the basal ganglia is functionally organized. Fur-
ther studies of matrix neurons, for example through optogenetic
approaches, are now feasible and will be important for a detailed
understanding of the functional division of the striatal patches
and matrix.
Methods
Experimental Animals
The studies were approved by the regional ethical commit-
tee on animal experiments (Swedish Board of Agriculture,
Jordbruksverket, permit: C79/9). The mouse lines used were:
Gt(ROSA)26Sortm14(CAG−tdTomato)Hze (tdTomato, Ai14) (Madisen
et al., 2010), Viaat-lx-lx (exon 2 of the Slc32a1 gene flanked
by loxP sites) (Tong et al., 2008), and Gpr101-Cre-A/B (herein
described). Mice were bred on C57BL/6 background and housed
at the animal facility of Uppsala Biomedical Center (Uppsala
University).
Generation of Gpr101-Cre Mice
The Gpr101-Cre construct was generated by recombineering
(Lee et al., 2001), introducing the Cre gene at the ATG site in the
first coding exon (exon 2) of the Gpr101 gene in a BAC. The BAC
covered approximately 150 kbp of genomic sequence upstream
of the Gpr101 start site, and 30 kbp of sequence downstream
of the of the Gpr101 gene. An overview of the recombineering
procedure is shown in Figure S1. We first generated a lin-
ear DNA containing nlsCre-SV40polyA-FRT-Kan/Neo-FRT,
flanked by two 50 bp homologous to sequences upstream or
downstream of Gpr101 exon 2 (Details available upon request).
The BAC (RP23-203E19, ChloramphenicolR, ChrX: 54711000-
54916304) was electroporated into EL250 cells, and seeded on
an LB agarose plate (chloramphenicol 12.5µg/ml). Successful
introduction of RP23-203E19 was confirmed by colony PCR
using the primers 5′-GAAGATAGCCACCCTGACCTT and
5′-TGCTCTTGTGTTCTGTTTTTGTG. Localizations of all
primers used for the colony PCRs are shown in Figure S1B.
Next, the nlsCre-SV40polyA-FRT-Kan/Neo-FRT construct was
inserted into exon 2 of Gpr101 in the BAC by homologous
recombination, mediated by EL250 endogenous recombination
proteins (Lee et al., 2001). Successful introduction of the Cre
construct into the BAC was confirmed by colony PCR using
the primers 5′-GCACAGGGATCTGAGAAAGG and 5′-AGGC
AAATTTTGGTGTACGG (detecting Cre insertion), and the
primers 5′-TCGCCTTCTTGACGAGTTCT and 5′-TGCTCTTG
TGTTCTGTTTTTGTG (detecting kanamycin insertion) on
chloramphenicol/kanamycin double resistant clones (LB agar
plates, chloramphenicol 12.5µg/ml; kanamycin 25µg/ml).
The kanamycin selection marker was subsequently deleted by
activation of EL250 indigenous Flp recombinases. This was
confirmed using the primers 5′-TGCTGGAAGATGGCGA
TTAG and 5′-CCCTTTGCCTGAAATGGTAA. Sequencing of
the BAC construct was performed using the primers 5′-TCCT
CTGCAAGGCACTAACC, 5′-CTGATTTCGACCAGGTTCGT,
5′-ATACCGGAGATCATGCAAGC, 5′-GACCGGCAAACG
GACAGAAG, 5′-CTGACCAGAGTCATCCTTAGC, and 5′-
TTATTTATCTGCCGTGTGGTGG. The modified BAC was
linearized by cleavage with NotI, and the backbone of the BAC
(containing a chloramphenicol resistance gene) was removed by
size-dependent fractionation through a custom-made sepharose
column. Fractions were inspected using Pulse Field Gel Elec-
trophoresis (CHEF mapper, Bio-Rad, CA) (Figure S1C). The
Grp101-Cre DNA construct was introduced randomly into the
mouse genome by pronuclear injection (Uppsala University
Transgenic Facility, Department of Medical Biochemistry and
Microbiology, BMC). The progeny was genotyped by PCR on tail
biopsies, using the primers: 5′-GCACAGGGATCTGAGAAAGG
and 5′-AGGCAAATTTTGGTGTACGG, and resulted in the
identification of 2 founder individuals (Figure S1D).
Genotyping
Mice were genotyped by PCR using tail biopsies, with the
following primers. Gpr101-Cre: 5′-GCACAGGGATCTGAGA
AAGG and 5′-AGGCAAATTTTGGTGTACGG. Viaat-lx-lx:
5′-TCCTTTGTGGCTTCCTTCCG (common forward primer),
5′-GGATAGAAGAAGTGTGGACC (gives differently sized
bands for wild-type Viaat and intact Viaat-lx-lx alleles), and
5′-GCAGTGGACCTTGGATGTCTATC (specific to excised
Viaatlx∗/lx∗ alleles). tdTomato: 5′-CTGTTCCTGTACGGCA
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TGG, 5′-GGCATTAAAGCAGCGTATCC, 5′-AAGGGAGCT
GCAGTGGAGTA, and 5′-CCGAAAATCTGTGGGAAGTC.
Tissue Preparation
Mice used for in situ hybridization and immunohistochemistry
were anesthetized by intraperitoneal (IP) injection of 1:1 Domi-
tor (70µg/g bodyweight, Orion) and Ketalar (7µg/g bodyweight,
Pfitzer) and transcardially perfused with PBS (0.1M Na2PO4,
pH 7.4) followed by 4% formaldehyde. Whole dissected brains
were further fixed at 4◦C overnight (spinal cords for ∼4 h) in
4% formaldehyde. The brains were sectioned to 60µm using a
vibratome (Leica, Germany).
Immunohistochemistry
The sections were rinsed with PBS and blocked in 0.3% Trition
X-100 in PBS with either 3% goat serum or a commercial block-
ing reagent (Roche Diagnostics), for 60-90min. Primary antibod-
ies were diluted in blocking buffer and incubated over night at
4◦C. List of antibodies, their suppliers and concentrations: NeuN
(Chemicon, Cat.MAB377) 1:400, ChAT (Chemicon, Cat. AB143)
1:100, DARPP32 (Novus Biologicals, Cat. NB100-79931) 1:800,
GFAP (Sigma-Aldrich, Cat. G3893) 1:1000, VIAAT (Synaptic
Systems, Cat. 131-011) 1:400, TH (Chemicon, Cat. AB152) 1:400,
CALB (Swant, Cat. CB38) 1:10000. The sections were washed
in PBS and incubated with the appropriate secondary antibod-
ies (conjugated to Alexa488 or Alexa568 (Invitrogen)) and DAPI
(Sigma-Aldrich) 1:1000 in PBS or PBT for 2–4 h at room temper-
ature. Immunolabeled sections were washed in PBT (0.1% Tween
20 in PBS) and 3-4 rounds of PBS, and mounted on glass slides
using Mowiol (Sigma-Aldrich). Minor modifications to the incu-
bations and washes were implemented to optimize the conditions
for each individual antibody. Immuno- and reporter RFP signals
were detected using a fluorescence microscope (BX61WI, Olym-
pus) or a confocal microscope (LSM 510 META, Zeiss). Images
were stacked using ImageJ (v1.46, NIH). Brightness and contrast
were uniformly adjusted using Photoshop CS3 (Adobe), and pic-
tures consisting of several overlapping image frames weremerged
using the function Photomerge (Photoshop CS3). Animals used
for immunohistochemistry were naive to behavioral tests and
VIAAT KO.
Combined In Situ Hybridization and
Immunohistochemistry
Antisense and sense in situ hybridization probes were gener-
ated by in vitro transcription of a linearized plasmid containing
cDNA sequence (D1, D2, or Viaat obtained from Invitrogen)
using T7, SP6 or T3 polymerase and labeled with digoxygenin
(Roche Applied Science) according to themanufacturer’s instruc-
tions. Sections for in situ hybridization were bleached in 6%
hydrogen peroxide for 15min at room temperature, followed
by washes in PBT, and then 0.5% Triton X-100 in PBS. After
cleansing in PBS, sections were digested with 20µg/ml Pro-
teinase K (Invitrogen), and postfixed in 4% formaldehyde before
preincubation in hybridization buffer (50% formamide, 5× SSC,
pH 4.5, 1% sodium dodecyl sulfate, 50µg/ml tRNA, 50µg/ml
heparin in PBT). Hybridization was carried out over night at
58◦C. To remove unbound probes, the sections were sequen-
tially incubated in a wash buffer (50% formamide, 5 × SSC,
pH 4.5, and 1% SDS in PBT), followed by incubation in a sec-
ond wash buffer (50% formamide, 2 × SSC, pH 4.5, in PBT)
at 58◦C. The sections were cleansed in PBS, and treated with a
commercial blocking buffer (Roche Diagnostics). Sections were
incubated overnight at 4◦C together with anti-digoxigenin alka-
line phosphatase-conjugated antibody diluted 1:5000 in blocking
buffer (Roche Diagnostics). Signal augmentation was achieved
by the use of Fast Red tablets (Roche Diagnostics). After devel-
opment, the tissues were washed in PBT supplemented with
0.1%, MP (Biomedicals). To visualize bleached RFP (since the
in situ procedure incapacitates the original RFP fluorescence)
from the tomato positive cells the sections were stained with
a rabbit antibody to RFP (Abcam, 1:200). Sections were incu-
bated with a secondary antibody [Alexa488-conjugated donkey
antibody to rabbit (Invitrogen) 1:400]. Sections were washed
in PBS to remove excessive secondary antibodies and mounted
on glass slides using Mowiol (Sigma-Aldrich). The slides were
scanned using a Zeiss LSM 510 META confocal microscope
and stacked using ImageJ (v1.46, NIH). Brightness and contrast
were uniformly adjusted using Photoshop CS3 (Adobe). Animals
used for in situ hybridization were naive to behavioral tests and
VIAAT KO.
Cell Counting and Size Measurements
Cell counting for the overlap between Gpr101-Cre-
Btg/wt :dtTomatotg/wt and DARPP32, D1 and D2 mRNA
was performed in ImageJ (v1.46, NIH) by manual counting on
confocal microscopy images (acquired as described in a previous
section), using five sections from two different individuals for
each staining (#sections total = 10 per staining). Measurements
of soma and nuclei diameters were also performed on confocal
images using ImageJ (v1.46, NIH).
Behavioral Tests
The Grip strength was measured by putting the mouse forepaws
on a wire mesh (BIO-GS3, Bioseb), and slowly pulling the mouse
back from the device by a tail grip until the animal released
the wire mesh. The Marble burying test (Deacon, 2006) was per-
formed by placing 18 black glass marbles in a grid pattern on top
of a 5 cm layer of sawdust bedding in a clean housing cage, and
counting the number of completely buried marbles after a mouse
had spent 30min in such an arena. The Elevated plus maze (Walf
and Frye, 2007) was situated 52 cm above the floor, and consisted
of four arms of which two had walls and two were open. The
mouse was placed in the center of the maze facing toward one
of the closed arms, and its activity during 10min in the maze
was video recorded. The illumination at the maze was main-
tained at 100 lux. AniTracker (rsutils) was used for the analysis
of the recorded data. Forced swim tests (Porsolt et al., 1977; Petit-
Demouliere et al., 2005) were executed in a Plexiglas cylinder
(20 cm in diameter), filled up to 25 cm depth with water (25◦C).
The trial lasted for 5min and was video recorded from above, and
the movement of the head during swimming was tracked using
custom software. The fraction time spent swimming, escaping, or
floating was manually scored during the first 90 s of video record-
ings using custom software that recorded the time that keyboard
buttons (representing the three behaviors) were pressed. In the
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Rotarod test (Dunham and Miya, 1957) the speed of the rotor
(IITC Life Science) was linearly increased from 0 to 45 rpm over
60 s, and the rpm at which the mouse fell from the rotating cylin-
der was recorded. Spontaneous and cocaine-induced Locomotion
were tracked using an open field chamber that was gridded by
infrared beams and detectors, which automatically counted the
number of dual beam breaks per time unit. KO and Ctrl mice
of matched body weight were tested simultaneously in identi-
cal open field chambers. The dose of cocaine was 15µg/g body
weight, and IP injected. Rearing activity was measured using the
same device as for locomotion, but with a beam grid located fur-
ther up from the floor of the arena. For theGait analysis, the mice
were trained to walk along a 1m x 50mm track with 15 cm high
walls, 1 day prior to testing. A bright light source was placed at
the start site and an escape box was located at the end of the track
to encourage locomotion. Initially, the mice were held in supine
restraint and their paws were mock-painted using a paintbrush.
They were then placed at the start of the track and had to tra-
verse to the end without stopping at least 3 times. During actual
testing, the procedure was repeated, but the hind paws were
painted blue and the forepaws red (Sense finger paints, Försäljn-
ing AB, Sweden). Footprints were recorded on chromatography
paper with 3–4 runs per mouse. Gait patterns were scanned as
an image, crosshairs were placed at each paw mark, and stride
length, limb overlap, and stride width were analyzed. The E-maze
used for the Object recognition test was constructed from black
plastic walls and a white inset floor (Overall size: 400 × 250 ×
210mm). The familiar objects were metal cones and the novel
object was a clean glass salt and pepper shaker with a metal lid.
The objects were approximately 100mm high× 50mm in diam-
eter. Exploration and interaction with the objects were recorded
by a ceiling-mounted video camera and manually scored using
AniTracker (rsutils). Mice were placed in the start arm (center)
and habituated to the empty arena for 3min. They were then
removed from the maze and placed into a holding cage while two
familiar objects were placed in the outer arms. The mice were
then returned to the start arm (center) and allowed to explore for
3min. At trial completion, the mice were returned to the home
cage for 2 h before the test was repeated; 3min of habituation,
followed by 3min of exploration of a familiar and novel object.
The time spent interacting with each object (being within 2 cm
distance) was recorded. Animals were used in multiple behav-
ioral tests, performed in the following order for the KOB/KOB-
Ctrl cohort (≥P56, and at least 3 days between each test): grip
strength, dominance tube, marble burying, elevated plus maze,
rotarod, forced swim, basal locomotion, cocaine-induced loco-
motion, and injection control (#KOB = 11, #Ctrl = 11 for all
test except the injection control in which #KOB = 6, #Ctrl = 6).
Behavioral tests for the KOA/KOA-Ctrl cohort were performed at
the following postnatal days: basal locomotion and rearing activ-
ity (P28, P35, P42, P49, P56), gait analysis (P60-61), grip strength
(P64), object recognition (P68) (#KOA = 5, #Ctrl = 6). Arenas
and equipment that were not completely replaced between trials
were washed with mild detergent and 70% ethanol to minimize
interference between consecutive behavioral tests. Any behav-
ioral tests that required manual scoring were performed blind to
the mouse genotype.
Statistical Analyses
Statistical significance of phenotypic differences between KO
and Ctrl mice were assessed in R (R Core Team, 2014) using
the following tests: Student’s two-sided t-test [Body weight,
grip strength, elevated plus maze (proportion of time spent
in areas)], forced swim test, rotarod test, locomotion (basal,
cocaine-induced, and injection control), rearing activity, gait
analysis, and object recognition test; two-sidedWilcoxon signed-
rank test [Elevated plus maze (number of entries) and marble
burying test]; two-sided binominal test (Dominance tube test);
Fisher’s exact test (Survivability).
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